Ageing

Antique clock
#Age-related diseases (ARDs) #Ageing #Epigenetics #Healthspan #Multiomics #Rejuvenation therapies

Turning back the epigenetic clock: Can we reverse ageing?

In this article, based on a session at Life Sciences Baltics 2025, Diana Turner reviews the latest research into epigenetics and rejuvenation.  An epigenetic clock is a biomarker of ageing that can be used to estimate ‘biological age’. The method relies on the modifications to DNA that… Read More

#Exclusive Content

Neuroscience innovation
#Ageing #Mass spectrometry / NMR #Neuroscience #Protein chemistry / Proteomics #Proteomics

Deciphering proteome alterations in neurodegeneration with mass spectrometry 

Daniel Hornburg PhD, Vice-President Biomarkers & Precision Medicine, Bruker Daltonics, Stefan Foser, Vice President Global Pharma, Bruker Daltonics, and Torsten Müller, Business Development Manager, Proteomics, Bruker Daltonics, explore how MS-based proteomics can be used to dissect disease biology with spatial resolution.   Impact of neurodegeneration for ageing societies… Read More

#Exclusive Content

Children excerising
#Ageing #Multiple sclerosis #Paediatrics #University of California San Diego

Evidence suggests accelerated ageing in children with MS

Researchers from University of California San Diego School of Medicine have discovered that children living with multiple sclerosis (MS) show signs of accelerated biological ageing, even in their teenage years.   The research published in Neurology, the medical journal of the American Academy of Neurology, is… Read More

#News

Grandfather and grandson
#Age-related diseases (ARDs) #Ageing #Rejuvenation therapies #Shift Bioscience #Transcriptomics

Novel single-gene target reverses cellular ageing

Biotechnology company Shift Bioscience has published new research identifying a novel, single-gene target for cellular rejuvenation.   Capable of reversing cellular ageing across multiple cell types, without inducing dangerous pluripotency pathways seen in other approaches, the company says SB000 is well positioned as a target for safer, next-generation… Read More

#Editor's Choice #News

Ageing hands
#Ageing #Healthspan #Junevity #Seed funding #siRNA #Transcriptomics

Biotech raises $10m to address ageing at a cellular level

Junevity, a biotechnology company hoping to extend lifespan and healthspan by resetting cell damage from age-related diseases, has announced $10 million in seed funding led by Goldcrest Capital and Godfrey Capital.  The Junevity RESET platform is based on exclusively licensed research by co-founder Dr Janine Sengstack at… Read More

#Business & Investment #News

Ageing concept
#Age-related diseases (ARDs) #Ageing #Start-ups

The start-up addressing ageing and disease

DDW Editor Reece Armstrong speaks to Dr Carina Kern, Chief Executive Officer and Chief Scientific Officer, and Serena Kern-Libera, Chief Operating Officer, at LinkGevity about the company’s approach to tackling age-related diseases. RA: Could you tell us about LinkGevity’s approach to developing broad-spectrum therapeutics in the field of ageing? … Read More

#Exclusive Content #Start-up Zone

#Age-related diseases (ARDs) #Ageing #Drug repurposing

How drug repurposing helps treat age-related diseases

Ann Belien, CEO at Rejuvenate Biomed, explores the need for more treatment options for age-related diseases and the opportunities drug repurposing offers these conditions. As the average global lifespan continues to rise, the prevalence of age-related diseases has become an increasing concern. Consequently, treatment options for those diseases are more… Read More

#Business & Investment #Exclusive Content

Neurons
#Ageing #CRISPR #Gene editing #Neuroscience #Regenerative Medicine #Stanford University

CRISPR gene editing reduces brain function decline with age

A new study has revealed that reducing the activity of a particular gene using CRISPR gene editing can rejuvenate stem cells in the brain to create fresh neurons. The finding in mice could open new avenues for potential therapeutics to improve brain function and reduce regenerative… Read More

#Editor's Choice #News

Collagen and vitamin drop skin cell
#Ageing #Cell and gene therapy #Gene therapy #Rejuvenation therapies

Using gene therapy to live longer, healthier lives

Sharon Rosenzweig-Lipson, PhD, is Chief Scientific Officer of Life Biosciences. She discusses with DDW’s Megan Thomas the company’s lead programme; a gene therapy called ER-100. Prolonging health span with drug development Life Biosciences aims to restore and prolong a patient’s health span by targeting the underlying biology of ageing and… Read More

#Exclusive Content

Ageing hands
#Age-related diseases (ARDs) #Ageing #Peptides #University of Birmingham

Natural peptide could protect against ‘inflammageing’

A naturally occurring peptide called ‘peptide inhibitor of trans-endothelial migration’ (PEPITEM) could potentially rejuvenate the immune response in older individuals, according to a new study. The authors believe the peptide could protect against ‘inflammageing’, widely believed to be the root cause of many age-related diseases. Read More

#News #Trending News

Laboratory mouse
#Ageing #Antibody #Duke-NUS Medical School #Healthspan #Imperial College London #Medical Research Council Laboratory of Medical Science #Mouse models

Anti-IL-11 drug extends lifespan by over 20% in mice

Scientists have discovered that ‘switching off’ protein interleukin 11 (IL-11) can significantly increase the healthy lifespan of mice by almost 25%. The scientists at the Medical Research Council Laboratory of Medical Science (MRC LMS) and Imperial College London, working with colleagues at Duke-NUS Medical School in… Read More

#Editor's Choice #News

#Ageing #Mergers and acquisitions #Rare disease #Sentynl Therapeutics

Sentynl buys treatment for rare ageing disease

Biopharmaceutical company Sentynl Therapeutics has acquired Eiger Biopharmaceuticals’ approved treatment for the rare disease progeria. Progeria, also known as Hutchinson-Gilford progeria syndrome (HGPS) and processing-deficient progeroid laminopathies (PDPL), in young people 12 months of age and older, are ultra-rare, fatal, genetic premature ageing diseases that accelerate mortality… Read More

#Business & Investment #News

Ageing hands
#Ageing #Artificial intelligence (AI) #Cancer research #Insilico Medicine #Transcriptomics #University of Chicago #University of Oslo

AI and transcriptomics identify dual targets for ageing and cancer

An international research team is the first to use artificial intelligence (AI) analysis to identify dual-purpose target candidates for the treatment of cancer and ageing. Researchers from the University of Oslo, University of Chicago Pritzker School of Medicine, and Insilico Medicine used Insilico’s AI target discovery… Read More

#Cancer Research #Editor's Choice #News

Age-related weak muscles
#Ageing #Rejuvenate Biomed #Sarcopenia

Advancing therapeutics to delay the onset of age-related diseases  

Rejuvenate Biomed, a clinical-stage company advancing therapeutics to delay the onset of age-related diseases, has completed a six-week clinical proof-of-mechanism study with lead candidate RJx-01 for the treatment of sarcopenia.   Sarcopenia is a musculoskeletal disease characterised by the progressive loss of skeletal muscle strength and mass,… Read More

#News

#Ageing #Cancer research #Epigenetics #Gene regulation #HKG Epitherapeutics #Precision medicine

The epigenetic edge: Harnessing precision medicine’s potential 

HKG Epitherapeutics is a biotechnology company developing novel tools for the early detection of cancer and promoting healthy aging. Founder Dr Moshe Szyf Founder shares the potential of harnessing precision medicine.  Embarking on a new era of medicine  The advent of genomics has ushered in… Read More

#Business & Investment #Exclusive Content #Opinion

Ageing hands
#Age-related diseases (ARDs) #Ageing #AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #University of Edinburgh

AI algorithms find drugs that could combat ageing

Three drugs that could help stave off the effects of ageing have been discovered using artificial intelligence (AI), a study by Edinburgh researchers suggests. Findings suggest the drugs can safely remove defective cells – known as senescent cells – linked to conditions including cancer, Alzheimer’s disease… Read More

#News